Merck has become the latest drugmaker to limit discounts on 340B drugs, saying it will stop giving 340B discounts on certain drugs unless hospitals provide claims data. The drugmaker sent a letter Aug ...
Merck will stop testing an experimental combination treatment for skin cancer patients in a late-stage study, the drugmaker said May 13. Merck was evaluating the use of the investigational ...
13d
Merck Congratulates Ontario Government on Expanding Pharmacy Scope to Help Improve Access to Care
Merck (NYSE: MRK), known as MSD outside the United States and Canada, congratulates the Government of Ontario for its recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results